close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

By: TheNewswire.com

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

More News

View More
GM Posts Largest Gain Since the Pandemic: Shares Still Look Cheap
Via MarketBeat
Topics World Trade
Tickers F GM TSLA
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
Via MarketBeat
Tickers ABBV AZN LLY
Tesla’s Earnings Review: Does the Juice Justify the Squeeze?
Via MarketBeat
Topics Earnings
Tickers TSLA
The Top 3 AI-Focused Defense Stocks to Put on Your Radar
Via MarketBeat
Topics Artificial Intelligence
Tickers LMT NOC RTX
Best Way to Invest in Gold Right Now—What Smart Money Is Doing
Via MarketBeat
Topics ETFs Economy
Tickers BAC GDX GLD NEM

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.29
+2.34 (1.07%)
AAPL  260.15
+1.70 (0.66%)
AMD  233.84
+3.61 (1.57%)
BAC  51.65
+0.55 (1.07%)
GOOG  255.24
+2.71 (1.07%)
META  738.39
+4.98 (0.68%)
MSFT  522.24
+1.70 (0.33%)
NVDA  181.97
+1.69 (0.94%)
ORCL  280.41
+7.75 (2.84%)
TSLA  443.88
+4.91 (1.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today